Revenue ($USD) : $23,414,400,000
Revenue (foreign currencies) : €21,680,000,000
R&D spend : $2,015,280,000
Employees : 71,000
Fiscal year end : 9/30/2023
CEO : Bernd Montag

www.siemens-healthineers.com

Siemens Healthineers reported good progress in its third quarter despite ongoing order delays in China. The German medtech giant now expects 4.5–6.5% sales growth for fiscal 2024. “Varian and Diagnostics especially contributed to the strong operating performance,” CEO Bernd Montag said in late July. Recent innovations at the company include the FDA-cleared Syngo Virtual Cockpit, a platform that enables real-time collaboration between healthcare professionals across different locations​​. The FDA also cleared the Magnetom Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner. The company said that scanner has the strongest gradients ever for a whole-body scanner, which improve the visibility of smaller structures and accelerates image captures. Additionally, Siemens Healthineers announced in March that its self-driving Ciartic Move mobile C-arm received an FDA clearance. Ciartic Move automates and accelerates imaging workflows in surgical environments​. Meanwhile, Varian in March announced clearance of its TrueBeam and Edge radiotherapy systems with HyperSight imaging. –CN